This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Hagar Greif: Innovator in Mitochondrial Protein Constructs
Introduction
Hagar Greif is an accomplished inventor based in Ness Ziona, Israel. He has made significant contributions to the field of mitochondrial research, particularly through his innovative patent related to mitochondrial protein constructs.
Latest Patents
Hagar Greif holds 1 patent for his work titled "Mitochondrial proteins constructs and uses thereof." This patent discloses fusion protein constructs that comprise a functional mitochondrial protein capable of entering mitochondria within intact cells. Additionally, the patent outlines methods for treating mitochondrial disorders using these fusion proteins and their compositions.
Career Highlights
Throughout his career, Hagar Greif has worked with notable organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Bioblast Pharma Ltd. His work in these companies has contributed to advancements in mitochondrial research and therapeutic applications.
Collaborations
Hagar has collaborated with Haya Lorberboum-Galski, a fellow researcher in the field. Their partnership has likely fostered innovative approaches to addressing mitochondrial disorders.
Conclusion
Hagar Greif's contributions to mitochondrial protein research exemplify the impact of innovative thinking in the scientific community. His patent and collaborations highlight the importance of advancing treatments for mitochondrial disorders.